Nimodipine after aneurysmal subarachnoid hemorrhage: shortened treatment in an unselected patient cohort

Background: Nimodipine improves outcome after aneurysmal subarachnoid hemorrhage (aSAH) through mitigation of delayed cerebral ischemia (DCI). Most studies are based on a treatment duration of 21 days. At our institution, clinical practice is to administer nimodipine for 14 days, regardless of bleed...

Full description

Bibliographic Details
Published in:Brain and Spine
Main Authors: Bryndís Baldvinsdóttir, Peo Wästberg, Björn M. Hansen, Erik Uvelius, Erik Kronvall
Format: Article
Language:English
Published: Elsevier 2025-01-01
Subjects:
Subarachnoid hemorrhage
Nimodipine
Delayed cerebral ischemia
Intracranial aneurysm
Vasospasm
Online Access:http://www.sciencedirect.com/science/article/pii/S277252942500195X

Internet

http://www.sciencedirect.com/science/article/pii/S277252942500195X

Similar Items